Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research – NCI Division of Cancer Prevention

NCI Division of Cancer Prevention shared a post on LinkedIn:

“New Funding Opportunity!

Through this NOFO, NCI encourages applications that support the biochemical and genetic analyses of cancer risk, and the discovery and validation of early detection biomarkers. Selected applicants will use the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.”

Read further.

More posts featuring NCI Division of Cancer Prevention.

Blog Posts

cancer colorectal cancer Lung cancer NCI Division of Cancer Prevention NCI-sponsored Prostate OncoDaily Oncology Ovarian Cancer PLCO Screening Trial